This company has been marked as potentially delisted and may not be actively trading. Athena Technology Acquisition (ATEK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOptions ChainOwnershipTrendsBuy This Stock ATEK vs. CRTX, OMCL, HSTM, MDRX, VACH, SIMA, HOND, POLE, VCIC, and JACSShould you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Voyager Acquisition (VACH), SIM Acquisition Corp. I (SIMA), HCM II Acquisition (HOND), Andretti Acquisition Corp. II (POLE), Vine Hill Capital Investment (VCIC), and Jackson Acquisition Co II (JACS). Athena Technology Acquisition vs. Cortexyme Omnicell HealthStream Veradigm Voyager Acquisition SIM Acquisition Corp. I HCM II Acquisition Andretti Acquisition Corp. II Vine Hill Capital Investment Jackson Acquisition Co II Athena Technology Acquisition (NYSE:ATEK) and Cortexyme (NASDAQ:CRTX) are both small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Which has more volatility & risk, ATEK or CRTX? Athena Technology Acquisition has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Cortexyme has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Do institutionals and insiders hold more shares of ATEK or CRTX? 17.3% of Athena Technology Acquisition shares are owned by institutional investors. Comparatively, 63.2% of Cortexyme shares are owned by institutional investors. 88.4% of Athena Technology Acquisition shares are owned by insiders. Comparatively, 27.9% of Cortexyme shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in ATEK or CRTX? Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote. CompanyUnderperformOutperformAthena Technology AcquisitionOutperform Votes63263.65% Underperform Votes36136.35% CortexymeOutperform Votes15464.44% Underperform Votes8535.56% Which has better earnings & valuation, ATEK or CRTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAthena Technology AcquisitionN/AN/AN/AN/AN/ACortexymeN/AN/A-$89.94M-$2.97-0.38 Is ATEK or CRTX more profitable? Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.Company Net Margins Return on Equity Return on Assets Athena Technology AcquisitionN/A N/A N/A Cortexyme N/A -70.96%-63.53% Does the media favor ATEK or CRTX? In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the media. Company Overall Sentiment Athena Technology Acquisition Neutral Cortexyme Neutral SummaryAthena Technology Acquisition beats Cortexyme on 5 of the 8 factors compared between the two stocks. Get Athena Technology Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATEK vs. The Competition Export to ExcelMetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE ExchangeMarket Cap$81.20M$460.77M$2.41B$18.91BDividend YieldN/A7.97%13.23%4.13%P/E RatioN/A2.3710.7732.57Price / SalesN/A56.223,504,142.3928.52Price / CashN/A69.0154.9917.53Price / BookN/A3.623.194.45Net IncomeN/A$35.22M-$305.73M$1.02B Athena Technology Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATEKAthena Technology AcquisitionN/A$8.00flatN/AN/A$81.20MN/A0.002,021CRTXCortexymeN/A$1.05flatN/A+6.1%$31.66MN/A-0.3555OMCLOmnicell2.4123 of 5 stars$31.01+1.0%$50.67+63.4%+14.1%$1.46B$1.11B115.083,800Analyst UpgradePositive NewsHSTMHealthStream3.3213 of 5 stars$33.03+1.4%$32.00-3.1%+28.4%$1.00B$291.65M50.621,140MDRXVeradigm2.5947 of 5 stars$4.20+1.2%$14.00+233.3%-44.7%$454.71M$1.53B0.008,000Analyst ForecastNews CoverageVACHVoyager AcquisitionN/A$10.260.0%N/AN/A$324.44MN/A0.00N/ASIMASIM Acquisition Corp. IN/A$10.25+0.2%N/AN/A$314.37MN/A0.00N/ANews CoveragePositive NewsHONDHCM II AcquisitionN/A$10.75+0.5%N/AN/A$309.06MN/A0.00N/ANews CoveragePositive NewsPOLEAndretti Acquisition Corp. IIN/A$10.16-0.4%N/AN/A$299.82MN/A0.00N/ANews CoveragePositive NewsVCICVine Hill Capital InvestmentN/A$10.22+0.0%N/AN/A$299.64MN/A0.00N/ANews CoveragePositive NewsJACSJackson Acquisition Co IIN/A$10.09-0.1%N/AN/A$298.56MN/A0.002 Related Companies and Tools Related Companies CRTX Alternatives OMCL Alternatives HSTM Alternatives MDRX Alternatives VACH Alternatives SIMA Alternatives HOND Alternatives POLE Alternatives VCIC Alternatives JACS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ATEK) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athena Technology Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athena Technology Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.